CN110505872A
|
|
Telomerase activation compound for fertility and related application
|
IL257470D0
|
|
Telomerase activating compounds for use in fertility and related applications
|
US2015178506A1
|
|
Method and system for database encryption
|
AU2014240314A1
|
|
Tri-aryl compounds and compositions comprising the same
|
IL230498D0
|
|
Spectral and temporal stealthy fiber optic communication using sampling and phase encoding detection system
|
IL227583D0
|
|
A vapor cell and a method and system for fabrication thereof
|
US2015076063A1
|
|
Method and apparatus for effecting high recovery desalination with pressure driven membranes
|
EP2838641A2
|
|
Method and apparatus for effecting high recovery desalination with pressure driven membranes
|
EP2764017A2
|
|
Compositions and methods for conferring herbicide resistance
|
IL220181D0
|
|
Antimicrobial water treatment membranes and production thereof
|
AU2011281114A1
|
|
Methods and compositions for inhibiting the nuclear factor kB pathway
|
AU2010245629A1
|
|
Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
|
AU2009211046A1
|
|
Insulin-like gene of prawns and uses thereof
|
EP1934348A1
|
|
Compositions for silencing the expression of vdac1 and uses thereof
|
AU2006260463A1
|
|
Method and apparatus for repositioning flow elements in a tapered flow structure
|
AU2005211584A1
|
|
Injectable Cross-Linked Polymeric Preparations and Uses Thereof
|
AU2005227775A1
|
|
Apparatus and method for the detection of one lung intubation by monitoring sounds
|
AU2004236057A1
|
|
Encapsulated essential oils
|
AU2002353485A1
|
|
Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
|